Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03032652
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.71 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2AH2 | 0.7 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2FHR | 0.7 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2A75 | 0.7 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A,B | 2VK7 | 0.7 | |
NAU | 4,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDONONANOIC ACID | A,C | 1F7B | 0.75 | |
AMN | 9-DEOXY-9-AMINO-2-O-METHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGJ | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.71 | |
G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWJ | 0.76 | |
G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWG | 0.76 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.72 | |
042 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.71 | |
75V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.71 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.73 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXV | 0.73 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXU | 0.73 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.71 | |
CRA | 1-DEOXY-1-METHOXYCARBAMIDO-BETA- D-GLUCO-2-HEPTULOPYRANOSONAMIDE | A | 1FS4 | 0.7 | |
CRA | 1-DEOXY-1-METHOXYCARBAMIDO-BETA- D-GLUCO-2-HEPTULOPYRANOSONAMIDE | A | 1B4D | 0.7 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR9 | 0.81 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B,C,D,E,F | 1O7A | 0.81 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR8 | 0.81 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.7 | |
76V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | A | 2DCB | 0.71 | |
H5M | TRANS-3-HYDROXY-5-METHYLPROLINE | A,B | 1A7Z | 0.72 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.75 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.75 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.75 | |
HMN | 2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID | A,B,C,D | 1F73 | 0.77 | |
GNA | 2,4-DEOXY-4-GUANIDINO-5-N-ACETYL- NEURAMINIC ACID | A | 2QWE | 0.71 |